Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Another major milestone announced for Wyeth Lederle Vaccines' pneumococcal vaccine

Oct. 22, 1999

Biogen places anti-CD40 ligand MAb studies on hold

Oct. 22, 1999

Preclinical data for FTY-720 presented at recent Japanese meetings

Oct. 22, 1999

Wyeth is first to cross the finish line with meningococcal group C conjugate vaccine

Oct. 22, 1999

Phase II clinical trials initiated for humanized anti-CD3 antibody developed at PDL

Oct. 21, 1999

North American Vaccine awarded contract to supply NeisVac-C in U.K.

Oct. 20, 1999

Chiron Behring, Abbott seek to terminate marketing agreements with North American Vaccines

Oct. 20, 1999

Antisense modulation of LFA-3 jointly investigated by Isis and Yale

Oct. 20, 1999

Trisulfide immunostimulants and their use in arteriosclerosis, etc.

Oct. 19, 1999

Progress toward a universal flu vaccine?

Oct. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...